articleTop 10% cited

FDA guidelines and animal models for osteoporosis

Bone · 1995 · Vol. 17(4) · pp. S125–S133

David D. Thompson✉Hollis A. Simmons(Pfizer (United States))C.M. Pirie(Pfizer (United States))H.Z. Ke(Pfizer (United States))

View via DOI Publisher page

Bone health and osteoporosis research Bone Metabolism and Diseases Estrogen and related hormone effectsOvariectomized ratOsteoporosisMedicineCancellous boneBone remodelingAnimal studiesInternal medicineEstrogenEndocrinologySurgery

MeSH terms

AgingAnimalsDisease Models, AnimalDrug Evaluation, PreclinicalFemaleHumansOvariectomyOvaryUnited StatesUnited States Food and Drug AdministrationOsteoporosis, PostmenopausalPractice Guidelines as TopicRats

Citations

523

FWCI

2.98

field-weighted impact

References

Percentile

91%

vs. same field & year

Citations per year

Cited by

Interspecies Differences in Bone Composition, Density, and Quality: Potential Implications for in Vivo Bone Research*

Endocrinology · 1998 · 745 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.